Bicalutamide 50mg (30 tablet count bottle label)
Bicalutamide Tablet
Product Images NDC 16729-023
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 16729-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig_1 (Bicalutamide Fig 1)
Fig_2 (Bicalutamide Fig 2)
This document appears to be a graph or chart showing the proportion of individuals not progressing on two different treatments over time. The treatments are labeled as "Bicalutamide plus LHRH-A" and "Flutamide plus LHRH-A". The x-axis appears to show the number of days since treatment began, with data points at 365, 730, 1095, and 1460 days. The y-axis appears to show the proportion of patients not progressing, with a label of "Days to progression" at 1825.*
Chem (Bicalutamide Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
